Screener
ADMA Biologics ADMA Gross Profit
Gross Profit at other companies
Other financials
Where this comes from
Calculated from ADMA Biologics’s reported figures.
The source filing: ADMA Biologics’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 5:16 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001140361-26-031445
| Line item | Three Months ended June 30, 2026 | Three Months ended June 30, 2025 | Six Months ended June 30, 2026 | Six Months ended June 30, 2025 |
|---|---|---|---|---|
| (In thousands, except share and per share data) | ||||
| REVENUES | $$124,395 | $121,984 | $238,888 | 236,786 |
| Cost of product revenue | 38,118 | 54,757 | 71,861 | 108,463 |
| Gross profit | 86,277 | 67,227 | 167,027 | 128,323 |
| OPERATING EXPENSES: | ||||
| Research and development | 6,014 | 1,031 | 8,611 | 1,858 |
| Plasma center operating expenses | 1,026 | 1,152 | 2,088 | 2,438 |
| Amortization of intangible assets | 55 | 32 | 110 | 57 |
Item 1. Financial Statements.
FAQ
- What is ADMA Biologics's gross profit?
- ADMA Biologics (ADMA) reported gross profit of $86.28M in Q2 2026.
- How has ADMA Biologics's gross profit changed year-over-year?
- ADMA Biologics's gross profit increased by 28.3% year-over-year, from $67.23M to $86.28M.
- What is the long-term trend for ADMA Biologics's gross profit?
- Over 4 years (2021 to 2025), ADMA Biologics's gross profit has grown at a 297.5% compound annual growth rate (CAGR), from $1.17M to $292.77M.
- What does gross profit mean?
- Revenue minus cost of revenue — the profit available to cover operating expenses, representing the company's pricing power and production efficiency.
Ask your AI about ADMA Biologics's gross profit.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude